Mga nangungunang video | CashInVids – Watch Videos & Earn Money Online

Bahay
Mga artikulo

Mga nangungunang video

Lahat ng oras

Ngayong araw

Ngayong linggo

Sa buwang ito

Ngayong taon

The Glory of the Transfiguration - Tuesday, August 6, 2024 Helena 106 Mga view • 2 taon kanina

*Then Peter said to Jesus in reply, “Rabbi, it is good that we are here! Let us make three tents: one for you, one for Moses, and one for Elijah.” He hardly knew what to say, they were so terrified. Then a cloud came, casting a shadow over them; from the cloud came a voice, “This is my beloved Son. Listen to him.”* Mark 9:5–7

Just prior to the Transfiguration, Jesus began to reveal to His disciples that He would suffer greatly, be rejected by the elders, be killed and then rise on the third day. This caused much fear for the disciples as they grappled with this unsettling revelation from our Lord. And even though Jesus remained firm with them and even rebuked Peter for his fear, Jesus also gave three of His disciples a very precious gift.

After much traveling, preaching, miracle working and private conversations about His passion with the Twelve, Jesus invited Peter, James and John to go with Him up a high mountain to pray. These disciples most likely had no idea what they would soon encounter. As they made the difficult and arduous journey, their minds must have been pondering not only the mighty deeds done by Jesus in the previous months but also His words about the suffering to come. As they struggled with this, much to their amazement, Jesus _“was transfigured before them, and his clothes became dazzling white.”_ Suddenly Moses and Elijah appeared before them, representing the Law and the prophets. These two Old Testament figures appeared as a way of saying to these disciples that everything that Jesus was telling them was to take place to fulfill all that had been foretold about Him from of old.
Perhaps Jesus thought that if His disciples would not fully listen to Him, then seeing Moses and Elijah would help. But Jesus went even further. The Voice of the Father Himself thundered and said, _“This is my beloved Son.
Listen to him.”_ Thus, if these disciples would not ultimately listen to Jesus alone, or if even Moses and Elijah failed to convince them, then the last hope was the Father Himself. And Jesus delivered such a grace.

The Transfiguration was a true mercy. These disciples had never seen anything like it before. But it was most likely this act of mercy that ultimately helped them to accept the hard truth that Jesus was trying to teach them about His coming suffering and death. If the Father in Heaven Personally gave witness to Jesus, then everything that Jesus had said was trustworthy.

As we read through the Gospels and the many teachings God has given us through the Church, think about whether there are some teachings with which you struggle? Or in your own life, on a personal level, are there some things you know God wants of you but you find it difficult to accept? When confusion sets in, that means we are not listening, are not fully hearing what God is saying to us or are not understanding...

Reflect, today, upon this powerful experience given to these disciples by our Lord. Try to place yourself in the scene so as to witness Jesus transfigured in the most glorious way, with Moses and Elijah and with the thundering Voice of the Father. Allow the Father to speak also to you, telling you that all He has spoken through the Scriptures, the Church and within your own conscience is true. Allow this revelation to convince you on the deepest level to acknowledge not only the divinity of Jesus but also to _“Listen to Him”_ in every way.

_My transfigured Lord, You are glorious beyond imagination, and You revealed a small glimpse of this glory to Your disciples to help them trust You more fully. May I also trust in You more completely, knowing that all You have spoken to me is true. Please remove any doubt and fear in my life so that nothing keeps me from embracing Your holy will. Jesus, I trust in You._
_______________________________________________
For more videos and reflections visit:
https://mycatholic.life

*CHAPTERS:*
0:00 Beginning
0:18 Scripture Quote
0:52 Daily Reflection
5:28 Final Meditation
6:18 Closing Prayer

Subscribe to My Catholic Life!: https://www.youtube.com/c/MyCa....tholicLifeJMJ?sub_co

Try Our Brand New App: https://mycatholic.life/apps
_______________________________________________
*Our Social Media:*
Facebook: https://facebook.com/catholic.daily.reflections
Twitter: https://twitter.com/CathDailyRef
Pinterest: https://pinterest.com/mycatholic
Tumblr: https://catholicdailyreflections.tumblr.com
Reddit: https://reddit.com/user/Catholic_Daily
Instagram: https://instagram.com/catholicdailyreflections
MeWe: https://mewe.com/p/catholicdailyreflections
Gab: https://gab.com/CatholicDailyReflections
________________________________________________
#catholic #gospel #reflection
Image: https://commons.wikimedia.org/....wiki/File:Duccio_di_

Ivermectin research 121gamers 45 Mga view • 4 buwan kanina

With Professor Colleen Aldous
Critical appraisal of multidrug therapy in the ambulatory
management of patients with COVID-19 and hypoxemia
Part II: Causal inference using the Bradford Hill criteria

https://www.jstage.jst.go.jp/a....rticle/antibiotics/7

We continue the critical appraisal of three published case series of 119 COVID-19 patients with hypoxemia, treated in the United States, Zimbabwe, and Nigeria with similar ivermectin-based multidrug treatments, to assess the available evidence supporting a causal relationship between treatment and reduction in hospitalizations and mortality. A narrative review was conducted to assess the Bradford Hill criteria for a causal association. We used a previously proposed refinement of the Bradford Hill criteria that reorganized them into three categories of direct, mechanistic, and
parallel evidence. The efficacy of the two most aggressive ivermectin-based
multidrug protocols is supported by the Bradford Hill criteria for temporality,
strength of association, biological gradient, biological plausibility, coherence, consistency, and analogy. The causal relation between the treatment of hypoxemic COVID-19 patients using these protocols and the reduction in hospitalizations and mortality is supported as an inference to the best explanation.

Critical appraisal of multidrug therapy in the ambulatory
management of patients with COVID-19 and hypoxemia
Part I. Evidence supporting the strength of association

https://faculty.utrgv.edu/elef....therios.gkioulekas/p

On March 11, 2020, Coronavirus Disease 2019 (COVID-19), the disease caused by the Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) [1]. Worldwide, 768,187,096 confirmed cases of COVID-19 and 6,945,714 deaths have been reported to the WHO as of June 21 2023, amounting to an average Case Fatality Rate (CFR) of 0.9% [2]. During 2020, while several governments and public health agencies were focused on contagion control and in-hospital patient care, several medical doctors from all around the world innovated and discovered early outpatient multidrug treatments using several repurposed medications in combination [3–15]. In the United States, several independent efforts coalesced into the formulation of a sequenced multidrug protocol [10, Fig. 3] (hereafter, McCullough protocol), which is based on the pathophysiological understanding of COVID-19 as a triphasic illness with three overlapping phases: (1) viral proliferation; (2) hyperinflammatory cytokine storm (COVID-19 pneumonia); and (3) thrombosis. McCullough’s protocol proposed a combination antiviral therapy for treating the viral proliferation phase, immunomodulators for treating the cytokine storm, and antiplatelet agents and antithrombotics for handling the thrombotic stage, based on risk stratification and how the disease presents in each individual patient. Thus, the McCullough protocol is an algorithmic treatment using sequenced multiple drugs in combination and customized to the individual patient and their response to treatment; no single drug is necessary nor sufficient to achieve treatment efficacy towards reducing hospitalizations and deaths. A recently published update of the McCullough protocol [16, Fig. 3] introduced some adjustments including virucidal nasal washes and oral gargles [17–24]. A large case series of 869 high-risk patients [25, 26], who were treated using an early version of the McCullough protocol, has been compared against population-level and historical controls [27], showing the existence of efficacy with respect to the reduction of mortality and hospitalizations, which is also resilient with respect to random selection bias, provided that patients are treated early enough within the first 3 to 5 days from the onset of illness. Indeed, an earlier study by Fazio et al.[28] showed that the ideal window of opportunity for initiating an effective early outpatient treatment of COVID-19 to prevent hospitalization is approximately within the first 3 days.